Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 128,083 | 1,241,201 | 1,187,530 | 965,734 | 158,979 |
| Depreciation Amortization | 11,013 | 43,158 | 32,022 | 20,987 | 10,461 |
| Accounts receivable | 2,501 | -29,143 | -34,335 | -5,671 | -829 |
| Other Working Capital | 70,454 | 234,449 | 115,824 | 61,662 | 11,349 |
| Other Operating Activity | 248,219 | 527,871 | 226,538 | 15,108 | 346,140 |
| Operating Cash Flow | $460,270 | $2,017,536 | $1,527,579 | $1,057,820 | $526,100 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -2,191,502 | N/A | N/A | N/A |
| PPE Investments | -85 | N/A | -2,019,768 | -683,741 | -503,070 |
| Purchase Of Investment | -278,983 | -1,455,609 | -955,356 | -799,222 | -531,638 |
| Sale Of Investment | 290,233 | 1,776,831 | 1,655,967 | 1,009,306 | 435,408 |
| Other Investing Activity | 0 | 0 | 523 | 523 | 0 |
| Investing Cash Flow | $11,165 | $-1,870,280 | $-1,318,634 | $-473,134 | $-599,300 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,272,533 | 1,272,533 | N/A | N/A |
| Common Stock Issued | 2,197 | 44,213 | 17,607 | 12,654 | 2,217 |
| Dividend Paid | -223,163 | -918,588 | -694,712 | -463,739 | -228,887 |
| Other Financing Activity | 0 | -13,046 | -12,245 | 0 | 0 |
| Financing Cash Flow | $-220,966 | $385,112 | $583,183 | $-451,085 | $-226,670 |
| Beginning Cash Position | 1,541,048 | 1,008,680 | 1,008,680 | 1,008,680 | 1,008,680 |
| End Cash Position | 1,791,517 | 1,541,048 | 1,800,808 | 1,142,281 | 708,810 |
| Net Cash Flow | $250,469 | $532,368 | $792,128 | $133,601 | $-299,870 |
| Free Cash Flow | |||||
| Operating Cash Flow | 460,270 | 2,017,536 | 1,527,579 | 1,057,820 | 526,100 |
| Capital Expenditure | -85 | N/A | -2,019,768 | -683,741 | -503,070 |
| Free Cash Flow | 460,185 | 2,017,536 | -492,189 | 374,079 | 23,030 |